New treatment for adults with acute lymphoblastic leukaemia

EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Aucatzyl (obecabtagene autoleucel) to treat adults from 26 years of age with…

Leave a Reply

Your email address will not be published. Required fields are marked *